To investigate the possible mechanism of thyroid hormone effects in lung development and function, we examined rabbit lung and two cell lines apparently derived from type I1 alveolar cells for specific nuclear binding of L-triiodothyronine (T3). Nuclei isolated from lung were incubated at 37 C for 1.5 h with various concentrations of [125~]-~3 in the presence and absence of excess non-labelled Tj, and then washed in buffer with 0.2% Triton X-100. In fetal lung, the concentration of T3 binding sites and the dissociation constant (Kd) were constant between 24-30 days gestation with mean*^^ values (n=17) of 0.67f0.05 fmollug DNA (2400 sites/cell) and 500f52 pM, respectively. Adult lung (n=3) bound 0.31f0.03 fmol T3/ug DNA (1120 siteslcell, p a l vs. fetal) and the Kd = 540f144 pM (NS). The L2 and A549 cell lines contained 2280 and 1580 nuclear siteslcell, and had Kd values of 200 and 280 pM, respectively. In fetal lung, the abil ity of analogs to compete for L-T3 binding (100%) was: 3,5-diiodo-3'-isopropylthyronine 81%, D-T3 73%, L-T4 6.7%. L-T2 0.19%, 3,5-dimethyl-3'-isopropyltbyronine 0.15%, and reverse T3 0.08%.
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We conclude that rabbit lung and cultured epithelial lung cells contain nuclear binding sites with a high affinity and specificity for thyroid hormones. This suggests that both fetal and adult lung and their type I1 cells may be directly influenced by these hormones. To determine the efficiency of conversion as a function of dose, relative amount of the biologically active metabolite of cortisone (E), hydrocortisone (F), available in systemic circulation was determined following the oral administration of 5 and 50 mg of E containing 1 to 6 uc 14C-E. 26 studies were done: 8 dell subjects; 7 children, adrenogenital syndrome; 5, growth hormo:re deficiency; 2, Crohn's disease. Plasma concentrations of F were determined by liquid scintillation counting following TLC separation using silica ge? HF-254 and a solvent system of methylene chloride-ethanal (90-10). Relative fraction of F which reaches the systemic circulation was estimated by using the area ~nder the plasma concentration time curve normalized for differences in the radioactive dose and surface area of the subject. (AUC'). AUC' values of F for 50 mg E given i.v. is only slightly greater than when 50 mg E was given orally, but the F to E ratio vas much greater by the oral route indicating a greater preponjerance of the E to F conversion pathway during the absorptive ~hase. Mean normalized AUC values (in units of percent radiolctive dose, liter-1, min.) for 5 and 50 mg dose were 283.5 SDt104.7) and 157.8 (SD30.6) respectively, (p-<O.OOl)indicatng almost a 50% difference in conversion efficiencies at two loses. Conclusion: Conversion of E to F is dose-dependent at 5 to 50 mg dosage range apparently due to saturable enzymes in :he gut.and liver and/or saturab1.e transcortin binding during thc bs.orptive 1s neede~h",~e~re~mh6V'tfa%aP%"o\Sb'e"pWrh,"S"cA&YC'se To assess the risks'of dehydration and hGodilutionad;ring potentially normal circumstances in patients treated with DDAVP, w e tested 9 children aged 7 2/12 -17 9/12 with central DI. In most children the urine volume and osmols were similar during the 3 days. Serum osmols hardly varied during normal fluid intake and water deprivation despite a mean 0. ---960 All patients were receiving GH at the time of T therapy. No acceleration of linear growth and no advance in osseous maturation occurred during or after treatment.
PHARMACOKINETIC ANALYSIS OF DOSE DEPENDENT
We conclude that local T for this brief period is a safe, effective, and simple means of stimulating phallic growth. Whether the effect is due to local tissue levels of elevated blood concentration of T remains to be demonstrated. To evaluate the role of gonadotropins in the control of Mullerian Inhibiting Substance (MIS) secretion, pregnant rats were injected with rabbit antiserum against luteinizing h o m n e releasing hormone (LHRH), and their pups replaced with luteinizing hormone (LH) and/or FSH. LHRH antiserum was given at 13 and 20 days of gestation. Male pups from mothers treated with LHRH anti serum were given 5 daily s.c. injections of FSH, LH, FSH and LH or vehicle. The male pups from mothers treated with normal rabbit serum were given vehicle s.0. Testicular fragments of 6-day old pups born to mothers treated with LHRH antiserum during pregnancy showed an increase relative to controls in MIS activity in a graded organ culture bioassay system (Grade 3.4s.2 vs. 2.05.0) ( p < 0.001). FSH replacement given to pups from mothers treated with LHRH antiserum reduced testicular MIS secretion compared to vehicle treated pups from the same mothers (Grade 2.5g.3 vs. 3.420.2) (p < 0.05). Postnatal FSH replacement after immunologic blockade of gonadotropins in utero reduced MIS activity of the testes to the same level as was found in testes of 6-day control pups. In contrast MIS activity remained high despite postnatal LH replacement in pups born to mothers given LHRH -AS (Grade 3.54.4 vs 3.4s.2) . These studies suggest that secretion of MIS is-dependent on normal hypothalamic secretion of LHRH and is under inhibitory FSH control. The clinical syndrome of neurogenic diabetes insipidus (DI) has recently been observed in three neonates. All cases were th products of complicated labors and deliveries and manifested symptoms of DI in the first 72 hours of life. Associated CNS abnormalities included metabolic encephalopathy, hemorrhage and cerebral hypoxia. Multiple quantitative measurements of serum antidiuretic hormone (ADH), during water deprivation with simultaneous urine and serum osmolalities and measurements of serum sodium, support the neurogenic form of DI.
Normal anterior pituitary function has been demonstrated in all cases by measurements of other trophic hormones and their products. These include serum TSH, T4, cortisols and growth hor mone. Hypothalamic dysfunction is strongly suggested by abnorma patterns Of growth hormone release to L-Dopa, elevated basal 1-I serum prolactin levels and abnormal prolactin response with normal TSH response to intravenous thyrotropin releasing hormone (TRH) .
I
. . This syndrome has been transient in one neonate, with resolution of the DI and accompanying normal serum ADH levels.
The DI has responded to treatment with parental pitressin as we1 as intranasal l-Desamino-8-D-Arginine vasopressin (DD-AVP).
We believe the syndrome of neurogenic DI may be considerablv more nates with CNS abnormalities than has previously
